To study a correlation between the ACCN2 expression level and survival prognosis for patients with primary and metastatic melanomas, we performed Kaplan-Meier analysis of the patient biopsies from the TCGA SKCM database. This evidence concerns the gene ASIC1 and metastatic melanoma.